The Face-Name Associative Memory Exam (FNAME) is a paired associative memory test created to detect memory deficits in individuals with preclinical Alzheimer's disease (AD). Worse performance on FNAME in cognitively healthy individuals were found related to higher amyloid beta (Aβ) burden measured with Positron-Emission-Tomography using 11 C-PiB (PiB-PET). We previously reported normative data of a Spanish version of FNAME (S-FNAME) in cognitively healthy Spanish-speaking subjects. The aim of the present study was to determine whether performance on S-FNAME was associated with Aβ burden in subjective cognitive decline (SCD) individuals. 200 SCD subjects received neurological and neuropsychological assessments, including the S-FNAME and the ...
Background: Subjective cognitive decline (SCD) is a target for Alzheimer's disease prediction. Plasm...
Neurofilament light chain (NfL) is an axonal protein that when measured in cerebrospinal fluid (CSF)...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer’s Di...
Background: There is a need for more sensitive neuropsychological tests to detect subtle cognitive d...
IntroductionThe Face Name Associative Memory Exam (FNAME) is sensitive to associative memory changes...
One current challenge for neuropsychologists is to design assessment methods capable of detecting co...
Purpose: To assess visual associative learning and famous face recognition ability among subjects wi...
ObjectiveThe Face-Name Associative Memory test (FNAME) has recently received attention as a test for...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer’s Di...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Werheid K, Clare L. Are faces special in Alzheimer's disease? Cognitive conceptualisation, neural co...
Abstract Background Peripheral biomarkers that identify individuals at risk of developing Alzheimer’...
Purpose: Argentina-Alzheimer’s Disease Neuroimaging Initiative (Arg-ADNI) is the first ADNI study to...
Recently, the focus of Alzheimer's disease (AD) research has shifted from the clinical stage to the ...
Background: Subjective cognitive decline (SCD) is a target for Alzheimer's disease prediction. Plasm...
Neurofilament light chain (NfL) is an axonal protein that when measured in cerebrospinal fluid (CSF)...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer’s Di...
Background: There is a need for more sensitive neuropsychological tests to detect subtle cognitive d...
IntroductionThe Face Name Associative Memory Exam (FNAME) is sensitive to associative memory changes...
One current challenge for neuropsychologists is to design assessment methods capable of detecting co...
Purpose: To assess visual associative learning and famous face recognition ability among subjects wi...
ObjectiveThe Face-Name Associative Memory test (FNAME) has recently received attention as a test for...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer’s Di...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's Di...
Werheid K, Clare L. Are faces special in Alzheimer's disease? Cognitive conceptualisation, neural co...
Abstract Background Peripheral biomarkers that identify individuals at risk of developing Alzheimer’...
Purpose: Argentina-Alzheimer’s Disease Neuroimaging Initiative (Arg-ADNI) is the first ADNI study to...
Recently, the focus of Alzheimer's disease (AD) research has shifted from the clinical stage to the ...
Background: Subjective cognitive decline (SCD) is a target for Alzheimer's disease prediction. Plasm...
Neurofilament light chain (NfL) is an axonal protein that when measured in cerebrospinal fluid (CSF)...
Objective: Subjective cognitive decline (SCD) is associated with an increased risk of Alzheimer’s Di...